Overview
Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient
Status:
No longer available
No longer available
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
Protocol to Allow Continued Access of Ficlatuzumab to P05538 PatientDetails
Lead Sponsor:
AVEO Pharmaceuticals, Inc.
Criteria
Inclusion Criteria:- Per original P05538 protocol
Exclusion Criteria:
- Per original P05538 protocol